1. Home
  2. DVA vs INGR Comparison

DVA vs INGR Comparison

Compare DVA & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • INGR
  • Stock Information
  • Founded
  • DVA 1994
  • INGR 1906
  • Country
  • DVA United States
  • INGR United States
  • Employees
  • DVA N/A
  • INGR N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • INGR Packaged Foods
  • Sector
  • DVA Health Care
  • INGR Consumer Staples
  • Exchange
  • DVA Nasdaq
  • INGR Nasdaq
  • Market Cap
  • DVA 9.7B
  • INGR 8.6B
  • IPO Year
  • DVA 1995
  • INGR 1997
  • Fundamental
  • Price
  • DVA $130.10
  • INGR $125.73
  • Analyst Decision
  • DVA Hold
  • INGR Hold
  • Analyst Count
  • DVA 3
  • INGR 5
  • Target Price
  • DVA $154.67
  • INGR $151.40
  • AVG Volume (30 Days)
  • DVA 663.6K
  • INGR 429.2K
  • Earning Date
  • DVA 10-28-2025
  • INGR 11-04-2025
  • Dividend Yield
  • DVA N/A
  • INGR 2.55%
  • EPS Growth
  • DVA 8.72
  • INGR 4.50
  • EPS
  • DVA 10.20
  • INGR 10.23
  • Revenue
  • DVA $13,161,328,000.00
  • INGR $7,316,000,000.00
  • Revenue This Year
  • DVA $5.96
  • INGR $2.02
  • Revenue Next Year
  • DVA $3.54
  • INGR $2.45
  • P/E Ratio
  • DVA $12.76
  • INGR $12.29
  • Revenue Growth
  • DVA 5.09
  • INGR N/A
  • 52 Week Low
  • DVA $126.07
  • INGR $120.51
  • 52 Week High
  • DVA $179.60
  • INGR $155.44
  • Technical
  • Relative Strength Index (RSI)
  • DVA 38.72
  • INGR 42.31
  • Support Level
  • DVA $131.77
  • INGR $125.17
  • Resistance Level
  • DVA $137.58
  • INGR $127.19
  • Average True Range (ATR)
  • DVA 2.61
  • INGR 1.88
  • MACD
  • DVA -0.54
  • INGR -0.17
  • Stochastic Oscillator
  • DVA 4.45
  • INGR 33.34

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.

Share on Social Networks: